<!DOCTYPE html>
<html>
<head>
    <title>全文阅读--XML全文阅读--中国知网</title>
    <link rel="icon" href="/kxreader/favicon.ico" />
    <link rel="shortcut Icon" href="/kxreader/favicon.ico" />
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
    <meta name="keywords" content="文献 XML KBASE CNKI 中国知网" />
    <meta name="description" content="XML文献检索" />
    <link href="/kxreader/Content/css/detail?v=NOOK-mvTMnxl11s6oPYV0boPXN3iP4N7Rc-A56nk4KI1" rel="stylesheet"/>

    <script type="text/javascript">
        var APPPATH = '/kxreader';
    </script>
</head>

<body>
    
<script type="text/javascript" src="//login.cnki.net/TopLogin/api/loginapi/get?type=top&amp;localCSS=&amp;returnurl=%2f%2fkns.cnki.net%2fKXReader%2fDetail%3fTIMESTAMP%3d637140995518725000%26DBCODE%3dCJFD%26TABLEName%3dCJFDLAST2019%26FileName%3dZGWT201901004%26RESULT%3d1%26SIGN%3dDZ1pU2J6rSxCBVeJMBWz9Tqowpg%253d"></script>

<div id="headerBox" class="header">
    <div class="topbar">
        <div class="textalign">
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=ZGWT201901004&amp;align=md">
                <i class="icon-cen active" title="居中对齐"></i>
            </a>
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=ZGWT201901004&amp;align=lt">
                <i class="icon-left " title="左对齐"></i>
            </a>
        </div>
        <h6 class="free-tip"><i class="icon"></i>HTML阅读开放试用阶段，欢迎体验！</h6>
    </div>
</div>

    



<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZGWT201901004&amp;v=MTY1OTMzenFxQnRHRnJDVVI3cWZadVpuRnkvaFc3N0FQeXJjZXJHNEg5ak1ybzlGWUlRS0RIODR2UjRUNmo1NE8=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRsbWlzblVrRUNCMVZEemR5T1VRND0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>

    <div class="main">

        

    <div class="sidebar-a">
        <!--sidebar start-->
        <div class="sidenav">
            <div class="arrow"><span></span></div>
            <!--sidebar_list start-->
            <dl class="sidenav-list">
                    <dt class="tit">目录结构</dt>
                            <dd class="guide">
                                    <p><a href="#139" data-title="&lt;b&gt;多个连续性共同终点优效性临床试验样本量估计方法&lt;/b&gt; "><b>多个连续性共同终点优效性临床试验样本量估计方法</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#155" data-title="1.方差已知的样本量估计方法">1.方差已知的样本量估计方法</a></li>
                                                <li><a href="#170" data-title="2.方差未知的样本量估计方法">2.方差未知的样本量估计方法</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#193" data-title="&lt;b&gt;多个共同终点非劣效临床试验样本量估计方法&lt;/b&gt; "><b>多个共同终点非劣效临床试验样本量估计方法</b></a><i></i></p>
                                                            </dd>
                            <dd class="guide">
                                    <p><a href="#201" data-title="&lt;b&gt;案例分析&lt;/b&gt; "><b>案例分析</b></a><i></i></p>
                                                            </dd>
                            <dd class="guide">
                                    <p><a href="#206" data-title="&lt;b&gt;讨&lt;/b&gt;&lt;b&gt;论&lt;/b&gt; "><b>讨</b><b>论</b></a><i></i></p>
                                                            </dd>
                            <dd class="guide">
                                    <p><a href="#" data-title="文内图表 ">文内图表</a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#204" data-title="&lt;b&gt;表1&lt;/b&gt; 某新型通气设备非劣效界值Δ设置情况"><b>表1</b> 某新型通气设备非劣效界值Δ设置情况</a></li>
                                                <li><a href="#208" data-title="&lt;b&gt;表2&lt;/b&gt; 全局把握度为80%不同参数设定下的样本量估计及Monte-Carlo模拟结果及"><b>表2</b> 全局把握度为80%不同参数设定下的样本量估计及Monte-Carlo模拟结果及</a></li>
                                    </ul>
                            </dd>
                                    <dd class="guide">
                                        <h6>
                                            <p><a href="#a_bibliography">参考文献</a> </p>
                                        </h6>
                                    </dd>

            </dl>
        </div>
        <!--sidebar end-->
        &nbsp;
        <!--此处有一空格符 勿删-->
    </div>

                <div class="sidebar-b three-collumn" style="width:0;">
            <div class="refer" style="width: 0;">
                <div class="arrow off" title="参考文献"><span></span></div>
                <div class="js-scrollbox" >
                    
                    <div class="subbox active">
                        <h4>
                            <span class="tit">参考文献</span>
                            <a class="close" href="javascript:void(0)">x</a>
                        </h4>
                        <div class="side-scroller">
                            <ul class="refer-list">
                                <li id="114">


                                    <a id="bibliography_1" title=" Sozu T, Sugimoto T, Hamasaki T, et al.Sample Size Determination in Clinical Trials with Multiple Endpoints.Springer International Publishing, 2015, 29 (21) :2169-2179." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Sample Size Determination in Clinical Trials with Multiple Endpoints">
                                        <b>[1]</b>
                                         Sozu T, Sugimoto T, Hamasaki T, et al.Sample Size Determination in Clinical Trials with Multiple Endpoints.Springer International Publishing, 2015, 29 (21) :2169-2179.
                                    </a>
                                </li>
                                <li id="116">


                                    <a id="bibliography_2" title=" Chuang-Stein C, Li JD.Commentary: Changes are still needed on multiple co-primary endpoints: Changes Are Still Needed on Multiple Co-Primary Endpoints.Statistics in Medicine, 2017, 36 (28) :4427-4436." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Commentary: Changes are still needed on multiple co-primary endpoints: Changes Are Still Needed on Multiple Co-Primary Endpoints">
                                        <b>[2]</b>
                                         Chuang-Stein C, Li JD.Commentary: Changes are still needed on multiple co-primary endpoints: Changes Are Still Needed on Multiple Co-Primary Endpoints.Statistics in Medicine, 2017, 36 (28) :4427-4436.
                                    </a>
                                </li>
                                <li id="118">


                                    <a id="bibliography_3" title=" Offen W, Chuang-Stein C, Dmitrienko A, et al.Multiple Co-primary Endpoints: Medical and Statistical Solutions: A Report from the Multiple Endpoints Expert Team of the Pharmaceutical Research and Manufacturers of America.Therapeutic Innovation &amp;amp; Regulatory Science, 2007, 41 (1) :31-46." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Multiple Co-primary Endpoints: Medical and Statistical Solutions: A Report from the Multiple Endpoints Expert Team of the Pharmaceutical Research and Manufacturers of America">
                                        <b>[3]</b>
                                         Offen W, Chuang-Stein C, Dmitrienko A, et al.Multiple Co-primary Endpoints: Medical and Statistical Solutions: A Report from the Multiple Endpoints Expert Team of the Pharmaceutical Research and Manufacturers of America.Therapeutic Innovation &amp;amp; Regulatory Science, 2007, 41 (1) :31-46.
                                    </a>
                                </li>
                                <li id="120">


                                    <a id="bibliography_4" title=" Committee for Medicinal Products for Human Use.Guideline on Medical Productsfor the Treatment Alzheimer’ Disease and Other Dementias (CPMP/EWP/553/95Rev.1) .European Medicines Agency, London, July 24, 2008." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Guideline on medicinal products for the treatment of Alzheimer&amp;#39;&amp;#39;s disease and other dementias">
                                        <b>[4]</b>
                                         Committee for Medicinal Products for Human Use.Guideline on Medical Productsfor the Treatment Alzheimer’ Disease and Other Dementias (CPMP/EWP/553/95Rev.1) .European Medicines Agency, London, July 24, 2008.
                                    </a>
                                </li>
                                <li id="122">


                                    <a id="bibliography_5" title=" Food and Drug Administration.Draft Guidance for Industry.Irritable Bowel Syndrome: Clinical Evaluation of Products for Treatment.Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, MD, March, 2010." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Draft Guidance for Industry.Irritable Bowel Syndrome: Clinical Evaluation of Products for Treatment">
                                        <b>[5]</b>
                                         Food and Drug Administration.Draft Guidance for Industry.Irritable Bowel Syndrome: Clinical Evaluation of Products for Treatment.Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, MD, March, 2010.
                                    </a>
                                </li>
                                <li id="124">


                                    <a id="bibliography_6" title=" Hamasaki T, Evans SR, Asakura K.Design, data monitoring, and analysis of clinical trials with co-primary endpoints: A review.Journal of Biopharmaceutical Statistics, 2017, 28 (1) :28-51." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Design,data monitoring,and analysis of clinical trials with co-primary endpoints: A review">
                                        <b>[6]</b>
                                         Hamasaki T, Evans SR, Asakura K.Design, data monitoring, and analysis of clinical trials with co-primary endpoints: A review.Journal of Biopharmaceutical Statistics, 2017, 28 (1) :28-51.
                                    </a>
                                </li>
                                <li id="126">


                                    <a id="bibliography_7" title=" 吴振强, 李卫, 孙业桓, 等.存在共同终点的优效性临床试验样本量问题探讨.中国卫生统计, 2013, 30 (5) :680-682." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZGWT201305016&amp;v=MzI3NjZHNEg5TE1xbzlFWW9RS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVpuRnkvaFc3N0FQeXJjZXI=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRsbWlzblVrRUNCMVZEemR5T1VRND0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[7]</b>
                                         吴振强, 李卫, 孙业桓, 等.存在共同终点的优效性临床试验样本量问题探讨.中国卫生统计, 2013, 30 (5) :680-682.
                                    </a>
                                </li>
                                <li id="128">


                                    <a id="bibliography_8" title=" Sozu T, Sugimoto T, Hamasaki T.Sample size determination in superiority clinical trials with multiple co-primary correlated endpoints.Journal of Biopharmaceutical Statistics, 2011, 21 (4) :650-668." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=STJD&amp;filename=STJD120604069062&amp;v=MTYwNDJ2bktyaWZaZVp2Rnluc1U3ak1LRjhjTmpuQmFySzZIdGZNcTQ5RGJlc0pEaE04enhVU21EZDlTSDduM3hFOWZi&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRsbWlzblVrRUNCMVZEemR5T1VRND0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[8]</b>
                                         Sozu T, Sugimoto T, Hamasaki T.Sample size determination in superiority clinical trials with multiple co-primary correlated endpoints.Journal of Biopharmaceutical Statistics, 2011, 21 (4) :650-668.
                                    </a>
                                </li>
                                <li id="130">


                                    <a id="bibliography_9" title=" 陈峰, 于浩.临床试验精选案例统计学解读.第1版.北京:人民卫生出版社, 2015:141-162" target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CBBD&amp;filename=9787117200714000&amp;v=MDcyOTl6R2JLNUdkUE1yNGhFWU9zUERCTTh6eFVTbURkOVNIN24zeEU5ZmJ2bktyaWZaZVp2Rnluc1U3ak1LRjhjWEZx&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRsbWlzblVrRUNCMVZEemR5T1VRND0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[9]</b>
                                         陈峰, 于浩.临床试验精选案例统计学解读.第1版.北京:人民卫生出版社, 2015:141-162
                                    </a>
                                </li>
                                <li id="132">


                                    <a id="bibliography_10" title=" 刘玉秀, 姚晨, 陈峰, 等.非劣效性/等效性试验中的统计学分析.中国临床药理学杂志, 2000, 16 (6) :448-452." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=GLYZ200006013&amp;v=MTg5NTlBSWlIU2RMRzRIdEhNcVk5RVo0UUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabkZ5L2hXNzc=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRsbWlzblVrRUNCMVZEemR5T1VRND0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[10]</b>
                                         刘玉秀, 姚晨, 陈峰, 等.非劣效性/等效性试验中的统计学分析.中国临床药理学杂志, 2000, 16 (6) :448-452.
                                    </a>
                                </li>
                                <li id="134">


                                    <a id="bibliography_11" title=" 陆梦洁, 刘玉秀, 卢光明, 等.单组目标值临床试验多指标时的样本量估计.中国临床药理学与治疗学, 2017, 22 (8) :917-921." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=YLZL201708015&amp;v=MjgxNzh0R0ZyQ1VSN3FmWnVabkZ5L2hXNzdBUENIUllyRzRIOWJNcDQ5RVlZUUtESDg0dlI0VDZqNTRPM3pxcUI=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRsbWlzblVrRUNCMVZEemR5T1VRND0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[11]</b>
                                         陆梦洁, 刘玉秀, 卢光明, 等.单组目标值临床试验多指标时的样本量估计.中国临床药理学与治疗学, 2017, 22 (8) :917-921.
                                    </a>
                                </li>
                                <li id="136">


                                    <a id="bibliography_12" title=" 郭正梅, 阎小妍, 姚晨.两个有序分类变量构建一个分类复合终点指标方法的模拟评价.中国卫生统计, 2014, 31 (2) :245-250." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZGWT201402017&amp;v=MTM4ODdUNmo1NE8zenFxQnRHRnJDVVI3cWZadVpuRnkvaFc3N0FQeXJjZXJHNEg5WE1yWTlFWTRRS0RIODR2UjQ=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRsbWlzblVrRUNCMVZEemR5T1VRND0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[12]</b>
                                         郭正梅, 阎小妍, 姚晨.两个有序分类变量构建一个分类复合终点指标方法的模拟评价.中国卫生统计, 2014, 31 (2) :245-250.
                                    </a>
                                </li>
                            </ul>
                            <div style='display: none;' class="zqscroller" >
                                <h4 class="">附加材料</h4>
                                <ul></ul>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            &nbsp;
            <!--此处有一空格符 勿删-->
        </div>

        
    <div class="content">



        <!--tips start-->
                            <div class="tips">
                    <a href="http://navi.cnki.net/KNavi/JournalDetail?pcode=CJFD&amp;pykm=ZGWT" target="_blank">中国卫生统计</a>
                2019,36(01),18-21+27             </div>
        <!--tips end-->
            <div class="top-title">
                <h1 class="title">
                    <span class="vm">多个连续性共同终点非劣效临床试验的样本量估计</span>
                                    </h1>

            </div>
                        <h2>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E5%91%A8%E6%86%A7%E6%86%A7&amp;code=37826329&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRsbWlzblVrRUNCMVZEemR5T1VRND0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">周憧憧</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E9%99%86%E6%A2%A6%E6%B4%81&amp;code=33823081&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRsbWlzblVrRUNCMVZEemR5T1VRND0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">陆梦洁</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E5%88%98%E7%8E%89%E7%A7%80&amp;code=41237017&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRsbWlzblVrRUNCMVZEemR5T1VRND0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">刘玉秀</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E9%99%88%E7%BE%BD&amp;code=26987161&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRsbWlzblVrRUNCMVZEemR5T1VRND0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">陈羽</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E5%88%98%E7%94%9C%E7%94%9C&amp;code=40485806&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRsbWlzblVrRUNCMVZEemR5T1VRND0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">刘甜甜</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E5%88%98%E9%9B%85%E7%90%A6&amp;code=35789380&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRsbWlzblVrRUNCMVZEemR5T1VRND0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">刘雅琦</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E5%8D%A0%E6%96%87%E5%BC%BA&amp;code=41237020&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRsbWlzblVrRUNCMVZEemR5T1VRND0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">占文强</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E8%B5%B5%E6%96%BD%E6%96%BD&amp;code=35753328&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRsbWlzblVrRUNCMVZEemR5T1VRND0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">赵施施</a>
                </h2>
                    <h2>
                    <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=in&amp;skey=%E5%8D%97%E4%BA%AC%E5%8C%BB%E7%A7%91%E5%A4%A7%E5%AD%A6%E5%85%AC%E5%85%B1%E5%8D%AB%E7%94%9F%E5%AD%A6%E9%99%A2%E7%94%9F%E7%89%A9%E7%BB%9F%E8%AE%A1%E5%AD%A6%E7%B3%BB&amp;code=0239762&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRsbWlzblVrRUNCMVZEemR5T1VRND0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">南京医科大学公共卫生学院生物统计学系</a>
                    <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=in&amp;skey=%E5%8D%97%E4%BA%AC%E5%86%9B%E5%8C%BA%E5%8D%97%E4%BA%AC%E6%80%BB%E5%8C%BB%E9%99%A2%E5%8C%BB%E5%AD%A6%E7%BB%9F%E8%AE%A1%E5%AD%A6%E6%95%99%E7%A0%94%E5%AE%A4&amp;code=0882417&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRsbWlzblVrRUNCMVZEemR5T1VRND0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">南京军区南京总医院医学统计学教研室</a>
                    <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=in&amp;skey=%E5%8D%97%E6%96%B9%E5%8C%BB%E7%A7%91%E5%A4%A7%E5%AD%A6%E5%85%AC%E5%85%B1%E5%8D%AB%E7%94%9F%E5%AD%A6%E9%99%A2%E7%94%9F%E7%89%A9%E7%BB%9F%E8%AE%A1%E5%AD%A6%E7%B3%BB&amp;code=0060982&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRsbWlzblVrRUNCMVZEemR5T1VRND0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">南方医科大学公共卫生学院生物统计学系</a>
                    <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=in&amp;skey=%E5%8D%97%E4%BA%AC%E5%8C%BB%E7%A7%91%E5%A4%A7%E5%AD%A6%E9%99%84%E5%B1%9E%E5%84%BF%E7%AB%A5%E5%8C%BB%E9%99%A2&amp;code=1051288&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRsbWlzblVrRUNCMVZEemR5T1VRND0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">南京医科大学附属儿童医院</a>
                    <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=in&amp;skey=%E6%B8%A9%E5%B7%9E%E5%8C%BB%E7%A7%91%E5%A4%A7%E5%AD%A6%E9%99%84%E5%B1%9E%E7%AC%AC%E4%B8%80%E5%8C%BB%E9%99%A2&amp;code=1698720&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRsbWlzblVrRUNCMVZEemR5T1VRND0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">温州医科大学附属第一医院</a>
            </h2>

        
<div class="link">
    <a id="aexport" class="icon icon-output"  onclick="" href="javascript:void(0);"><i></i>导出/参考文献</a>
    
    <span class="shareBoard" onmouseover="$('#sharedet').show();$('#this').addClass('shareBoardCUR')" onmouseout="$('#sharedet').hide();$('#this').removeClass('shareBoardCUR')">
        <a class="icon icon-share" href="#"><i></i>分享<em></em></a>
        <ul class="shareHide" id="sharedet" style="display: none;">
            <li><a title="复制链接" class="copy" onclick="" href="#"><i></i>复制链接</a></li>
            <li><a title="分享到新浪微博" class="xl" onclick="" href="javascript:common.ShareAction('xl');"><i></i>新浪微博</a></li>
            <li>
                <a title="分享到微信" class="wx" onclick="" href="#"><i></i>微信扫一扫</a>
                <div class="qrcode"><img src='' alt='' /></div>
            </li>
        </ul>

    </span>
    
    <a id="RefTrack" title="创建引文跟踪" class="icon icon-track" onclick="" href="javascript:void(0);"> <i></i>创建引文跟踪 </a>
    <a id="ashoucang" title="收藏" class="icon icon-favor" onclick="" href="javascript:void(0);"><i></i>收藏</a>
    <a class="icon icon-print" onclick="window.print();" href="javascript:void(0);"><i></i>打印</a>
    
    <!--版本切换 end-->
</div>
                            <div class="data" id="a_abstract">
                <span class="keys">摘<span style="font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;</span>要：</span>
                <p>目的 针对多个以连续性正态分布变量作为共同终点的非劣效临床试验, 探讨保护全局把握度的样本量估计方法。方法 在阐明优效性临床试验多个连续性共同终点样本量估计的理论基础上, 扩展提出了关于非劣效临床试验多个连续分布共同终点的样本量估计方法。结合临床麻醉学中一个重复测量终点非劣效临床试验的实际案例, 基于其预试验的相关结果, 在不同的I类错误水平、各重复测量间不同的相关系数、不同的非劣效界值设定下, 估计了满足一定的全局把握度 (例如80%) 的样本量, 并借助Monte-Carlo模拟方法对估计结果进行验证。结果 本文介绍的非劣效临床试验多个连续性正态分布共同终点的样本量估计方法具有严密的统计理论基础, 表明能较好的保护全局把握度, 结合实际案例进行的样本量估计结果模拟研究验证了方法的正确性。结论 本文为非劣效临床试验多个连续分布共同终点的样本量估计提供了方法学支持, 具有较强的实用价值。</p>
            </div>
                    <div class="data" id="a_keywords">
                <span class="keys">关键词：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E9%9D%9E%E5%8A%A3%E6%95%88%E4%B8%B4%E5%BA%8A%E8%AF%95%E9%AA%8C&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRsbWlzblVrRUNCMVZEemR5T1VRND0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">非劣效临床试验;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E5%85%B1%E5%90%8C%E7%BB%88%E7%82%B9&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRsbWlzblVrRUNCMVZEemR5T1VRND0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">共同终点;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E5%85%A8%E5%B1%80%E6%8A%8A%E6%8F%A1%E5%BA%A6&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRsbWlzblVrRUNCMVZEemR5T1VRND0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">全局把握度;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E6%A0%B7%E6%9C%AC%E9%87%8F&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRsbWlzblVrRUNCMVZEemR5T1VRND0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">样本量;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Monte-Carlo%E6%A8%A1%E6%8B%9F&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRsbWlzblVrRUNCMVZEemR5T1VRND0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Monte-Carlo模拟;</a>
                </p>
            </div>
        
        <!--brief start-->
        
            <div class="brief">
                    <p>
                            <b>作者简介：</b>
                                                        <span>
                                    *刘玉秀, E-mail:liu_yuxiu@163.com;
                                </span>
                    </p>
                
                    <p>

                            <b>基金：</b>
                                                        <span>国家自然科学基金面上项目 (81473066);</span>
                    </p>
            </div>
                    <h1>Sample Size Determination with Multiple Co-primary Continuous Endpoints in Non-inferiority Trials</h1>
                    <h2>
                    <span>Zhou Chongchong</span>
                    <span>Lu Mengjie</span>
                    <span>Liu Yuxiu</span>
            </h2>
                    <h2>
                    <span>Department of Biostatistics, School of Public Health, Nanjing Medical University</span>
            </h2>
                            <div class="data" id="a_abstractEN">
                <span class="keys">Abstract：</span>
                <p>Objective To explore a sample size determination that protects overall power in non-inferiority clinical trials with multiple co-primary continuous endpoints.Methods Based on theoretical analysis of the sample size determination with co-primary endpoints in superiority clinical trials, the sample size determination with multiple co-primary continuous endpoints was proposed in non-inferiority clinical trials and was applied in clinical anaesthesiology to estimate the sample size which is repeated measurement.According to pre-experiment, the sample size was estimated to control the overall power (eg.80%) with different levels of the type I error rate, different correlation coefficients and different non-inferiority margins among continuous normal distribution variables.The Monte Carlo simulation method is used to verify the estimation result.Results The sample size determination in co-primary continuous endpoints in non-inferiority clinical trials described in this paper has a strict statistical theory basis and could protect the overall power better which is verified by Monte Carlo simulation with the case study.Conclusion The method in the paper provides methodological support for the sample size determination with co-primary continuous endpoints in a non-inferiority clinical trials which has strong practical value.</p>
            </div>
                    <div class="data" id="a_keywordsEN">
                <span class="keys">Keyword：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Non-inferiority%20clinical%20trials&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRsbWlzblVrRUNCMVZEemR5T1VRND0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Non-inferiority clinical trials;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Co-primary%20endpoints&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRsbWlzblVrRUNCMVZEemR5T1VRND0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Co-primary endpoints;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Overall%20power&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRsbWlzblVrRUNCMVZEemR5T1VRND0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Overall power;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Sample%20size&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRsbWlzblVrRUNCMVZEemR5T1VRND0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Sample size;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Monte-Carlo%20simulation&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRsbWlzblVrRUNCMVZEemR5T1VRND0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Monte-Carlo simulation;</a>
                </p>
            </div>
        

        <!--brief start-->
                        <div class="p1">
                    <p id="138">在许多临床试验中, 由于病人对治疗的反应可能是多方面的, 因此其疗效常常不能由单一的指标完全反映, 而需要由一系列可能相关的指标才能综合反映出来, 这就是所谓的共同终点 (co-primary endpoints) 。从统计推断意义上看, 共同终点是指多个终点同时具有统计学意义, 方可声称药物或者器械的有效性, 此时采用的是联合检验, 不需调整I类错误, 但II类错误会随着终点个数的增加而膨胀<citation id="225" type="reference"><link href="114" rel="bibliography" /><link href="116" rel="bibliography" /><sup>[<a class="sup">1</a>,<a class="sup">2</a>]</sup></citation>。近年来, 随着多终点临床试验的开展日益增多, 有关多个共同终点临床试验的样本量估计问题引起人们关注<citation id="224" type="reference"><link href="118" rel="bibliography" /><link href="120" rel="bibliography" /><link href="122" rel="bibliography" /><link href="124" rel="bibliography" /><sup>[<a class="sup">3</a>,<a class="sup">4</a>,<a class="sup">5</a>,<a class="sup">6</a>]</sup></citation>。既往常按单个终点分别估计并选择最大值的方法, 但该方法既没有考虑多终点间的相关性, 也很难通过控制II类错误率发生达到预定的全局把握度<citation id="226" type="reference"><link href="126" rel="bibliography" /><sup>[<a class="sup">7</a>]</sup></citation>。2011年Suzu<citation id="227" type="reference"><link href="128" rel="bibliography" /><sup>[<a class="sup">8</a>]</sup></citation>等阐明了优效性临床试验多个相关终点作为共同终点的样本量估计方法, 解决了多终点间非独立以及保护全局把握度的问题。本文将在优效性临床试验样本量估计方法的基础上, 扩展提出非劣效临床试验多个连续性共同终点的样本量估计方法, 并结合临床麻醉学中一个重复测量终点非劣效临床试验的实际案例, 在不同的参数设置下, 进行样本量估计和Monte-Carlo模拟验证。</p>
                </div>
                <h3 id="139" name="139" class="anchor-tag"><b>多个连续性共同终点优效性临床试验样本量估计方法</b></h3>
                <div class="p1">
                    <p id="140">在随机对照临床试验中, 假定试验组有<i>n</i><sub>1</sub>例, 对照组有<i>n</i><sub>2</sub>例。假定有<i>K</i>个共同终点且服从<i>K</i>元正态分布 (<i>K</i>≥2) 。试验组<i>n</i><sub>1</sub>例受试者的响应值记为<i>Y</i><sub>1</sub><sub><i>jk</i></sub>, <i>j</i>=1, …, <i>n</i><sub>1</sub>, 对照组<i>n</i><sub>2</sub>例受试者的响应值记为<i>Y</i><sub>2</sub><sub><i>jk</i></sub> , <i>j</i>=1, …, <i>n</i><sub>2</sub>, <i>k</i>=1, …, <i>K</i>。将其写成向量形式即为:</p>
                </div>
                <div class="p1">
                    <p id="141"><i>Y</i><sub>1<i>j</i></sub>= (<i>Y</i><sub>1<i>j</i>1, …, </sub><i>Y</i><sub>1<i>jK</i></sub>) <sup><i>T</i></sup> , <i>Y</i><sub>2<i>j</i></sub>= (<i>Y</i><sub>2<i>j</i>1, …, </sub><i>Y</i><sub>2<i>jK</i></sub>) <sup><i>T</i></sup></p>
                </div>
                <div class="p1">
                    <p id="142">两者均服从<i>K</i>元正态分布, 其均向量分别为:</p>
                </div>
                <div class="p1">
                    <p id="143"><i>E</i>[<i>Y</i><sub>1<i>j</i></sub>]=<i>μ</i><sub>1</sub>= (<i>μ</i><sub>11</sub>, …, <i>μ</i><sub>1<i>K</i></sub>) <sup><i>T</i></sup> , <i>E</i>[<i>Y</i><sub>2<i>j</i></sub>]=<i>μ</i><sub>2</sub>= (<i>μ</i><sub>21</sub>, …, <i>μ</i><sub>2<i>K</i></sub>) <sup><i>T</i></sup> , </p>
                </div>
                <div class="p1">
                    <p id="144">协方差阵为∑:</p>
                </div>
                <div class="p1">
                    <p id="145" class="code-formula">
                        <mathml id="145"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mstyle displaystyle="true"><mo>∑</mo><mo>=</mo></mstyle><mrow><mo> (</mo><mrow><mtable><mtr><mtd><mi>σ</mi><msubsup><mrow></mrow><mn>1</mn><mn>2</mn></msubsup></mtd><mtd><mo>⋯</mo></mtd><mtd><mi>ρ</mi><msup><mrow></mrow><mrow><mn>1</mn><mi>Κ</mi></mrow></msup><mi>σ</mi><msub><mrow></mrow><mn>1</mn></msub><mi>σ</mi><msub><mrow></mrow><mi>Κ</mi></msub></mtd></mtr><mtr><mtd><mo>⋮</mo></mtd><mtd><mo>⋮</mo></mtd><mtd><mo>⋮</mo></mtd></mtr><mtr><mtd><mi>ρ</mi><msup><mrow></mrow><mrow><mn>1</mn><mi>Κ</mi></mrow></msup><mi>σ</mi><msub><mrow></mrow><mn>1</mn></msub><mi>σ</mi><msub><mrow></mrow><mi>Κ</mi></msub></mtd><mtd><mo>⋯</mo></mtd><mtd><mi>σ</mi><msubsup><mrow></mrow><mi>Κ</mi><mn>2</mn></msubsup></mtd></mtr></mtable></mrow><mo>) </mo></mrow></mrow></math></mathml>
                    </p>
                </div>
                <div class="p1">
                    <p id="147">其中假设<i>Y</i><sub>1<i>jk</i></sub>和<i>Y</i><sub>2<i>jk</i></sub>方差相等, 均为<i>σ</i><mathml id="148"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><msubsup><mrow></mrow><mi>k</mi><mn>2</mn></msubsup></mrow></math></mathml>, <i>Y</i><sub>1<i>jk</i></sub>与<i>Y</i><sub>1<i>jk</i>′</sub>的相关系数和<i>Y</i><sub>2<i>jk</i></sub>与<i>Y</i><sub>2<i>jk</i>′</sub>的相关系数相同, 均为<i>ρ</i><sup><i>kk</i>′</sup> (<i>k</i>≠<i>k</i>′, 1≤<i>k</i>≤<i>k</i>′≤<i>K</i>) 。</p>
                </div>
                <div class="p1">
                    <p id="149">在优效性临床试验中, 关注的是两组均数的差值, 假设各终点指标均为高优指标。</p>
                </div>
                <div class="p1">
                    <p id="150"><i>δ</i><sub><i>k</i></sub>=<i>μ</i><sub>1<i>k</i></sub>-<i>μ</i><sub>2<i>k</i></sub>, <i>δ</i><sub><i>k</i></sub>&gt;0 代表诊疗有益</p>
                </div>
                <div class="p1">
                    <p id="151">进行优效性假设:</p>
                </div>
                <div class="p1">
                    <p id="152"><i>H</i><sub>0</sub>:<i>δ</i><sub><i>k</i></sub>≤0 , 只要有一个<i>k</i>满足</p>
                </div>
                <div class="p1">
                    <p id="153"><i>H</i><sub>1</sub>:<i>δ</i><sub><i>k</i></sub>&gt;0 , 所有<i>k</i>均需要满足</p>
                </div>
                <div class="p1">
                    <p id="154">基于上述的假设, 当且仅当所有单个终点均在检验水准<i>α</i>下被拒绝时其原假设<i>H</i><sub>0</sub> 才能被拒绝, 其拒绝域是<i>K</i>个终点拒绝域的交集, 故多个共同终点的检验属于交并检验 (intersection-union test, IUT) 。</p>
                </div>
                <h4 class="anchor-tag" id="155" name="155">1.方差已知的样本量估计方法</h4>
                <div class="p1">
                    <p id="156">为简单起见, 假定<i>σ</i><mathml id="157"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><msubsup><mrow></mrow><mi>k</mi><mn>2</mn></msubsup></mrow></math></mathml>已知 (可从先前的试验或预试验中获取) 。在这种假定下, 每个终点的均数之差的检验统计量可以用<i>Z</i>统计量表示:</p>
                </div>
                <div class="p1">
                    <p id="158" class="code-formula">
                        <mathml id="158"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mi>Ζ</mi><msub><mrow></mrow><mi>k</mi></msub><mo>=</mo><mfrac><mrow><mover accent="true"><mi>Y</mi><mo>¯</mo></mover><msub><mrow></mrow><mrow><mn>1</mn><mi>k</mi></mrow></msub><mo>-</mo><mover accent="true"><mi>Y</mi><mo>¯</mo></mover><msub><mrow></mrow><mrow><mn>2</mn><mi>k</mi></mrow></msub></mrow><mrow><mi>σ</mi><msub><mrow></mrow><mi>k</mi></msub><msqrt><mrow><mfrac><mn>1</mn><mrow><mi>n</mi><msub><mrow></mrow><mn>1</mn></msub></mrow></mfrac><mo>+</mo><mfrac><mn>1</mn><mrow><mi>n</mi><msub><mrow></mrow><mn>2</mn></msub></mrow></mfrac></mrow></msqrt></mrow></mfrac><mo>‚</mo><mspace width="0.25em" /><mi>k</mi><mo>=</mo><mn>1</mn><mo>, </mo><mo>⋯</mo><mo>‚</mo><mi>Κ</mi></mrow></math></mathml>
                    </p>
                </div>
                <div class="p1">
                    <p id="159">其中<mathml id="160"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mover accent="true"><mi>Y</mi><mo>¯</mo></mover><msub><mrow></mrow><mrow><mn>1</mn><mi>k</mi></mrow></msub><mo>=</mo><mfrac><mn>1</mn><mrow><mi>n</mi><msub><mrow></mrow><mn>1</mn></msub></mrow></mfrac><mstyle displaystyle="true"><munderover><mo>∑</mo><mrow><mi>j</mi><mo>=</mo><mn>1</mn></mrow><mrow><mi>n</mi><msub><mrow></mrow><mn>1</mn></msub></mrow></munderover><mi>Y</mi></mstyle><msub><mrow></mrow><mrow><mn>1</mn><mi>j</mi><mi>k</mi></mrow></msub><mo>‚</mo><mover accent="true"><mi>Y</mi><mo>¯</mo></mover><msub><mrow></mrow><mrow><mn>2</mn><mi>k</mi></mrow></msub><mo>=</mo><mfrac><mn>1</mn><mrow><mi>n</mi><msub><mrow></mrow><mn>2</mn></msub></mrow></mfrac><mstyle displaystyle="true"><munderover><mo>∑</mo><mrow><mi>j</mi><mo>=</mo><mn>1</mn></mrow><mrow><mi>n</mi><msub><mrow></mrow><mn>2</mn></msub></mrow></munderover><mi>Y</mi></mstyle><msub><mrow></mrow><mrow><mn>2</mn><mi>j</mi><mi>k</mi></mrow></msub></mrow></math></mathml>。如果<i>Y</i><sub>1<i>jk</i></sub>, <i>Y</i><sub>2<i>jk</i></sub>均服从正态分布, 那么Z统计量Z= (<i>Z</i><sub>1</sub>, …, <i>Z</i><sub><i>K</i></sub>) <sup><i>T</i></sup>服从均向量为<mathml id="161"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><msqrt><mrow><mi>r</mi><mi>n</mi><mo>/</mo><mo stretchy="false"> (</mo><mn>1</mn><mo>+</mo><mi>r</mi><mo stretchy="false">) </mo></mrow></msqrt><mrow><mo stretchy="false"> (</mo><mi>δ</mi><msubsup><mrow></mrow><mn>1</mn><mo>*</mo></msubsup><mo>, </mo><mo>⋯</mo><mo>‚</mo><mi>δ</mi><msubsup><mrow></mrow><mi>Κ</mi><mo>*</mo></msubsup><mo stretchy="false">) </mo></mrow><msup><mrow></mrow><mi>Τ</mi></msup></mrow></math></mathml>、协方差阵为<i>ρ</i>的多元正态分布。其中<i>δ</i><sup>*</sup><sub><i>k</i></sub>是标准效应量, <i>δ</i><sup>*</sup><sub><i>k</i></sub>=<i>δ</i><sub><i>k</i></sub>/<i>σ</i><sub><i>k</i></sub>, <i>r</i>=<i>n</i><sub>2</sub>/<i>n</i><sub>1</sub>, <i>n</i>=<i>n</i><sub>1</sub>, <i>n</i>为试验组样本量, <image id="221" type="formula" href="images/ZGWT201901004_22100.jpg" display="inline" placement="inline"><alt></alt></image><image id="221" type="formula" href="images/ZGWT201901004_22101.jpg" display="inline" placement="inline"><alt></alt></image>, 因此全局把握度为:</p>
                </div>
                <div class="p1">
                    <p id="164" class="code-formula">
                        <mathml id="164"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mn>1</mn><mo>-</mo><mi>β</mi><mo>=</mo><mtext>Ρ</mtext><mtext>r</mtext><mtext>o</mtext><mtext>b</mtext><mrow><mo>[</mo><mrow><mstyle displaystyle="true"><munderover><mo>∩</mo><mrow><mi>k</mi><mo>=</mo><mn>1</mn></mrow><mi>Κ</mi></munderover><mrow><mrow><mo>{</mo><mrow><mi>Ζ</mi><msub><mrow></mrow><mi>k</mi></msub><mo>&gt;</mo><mi>z</mi><msub><mrow></mrow><mi>α</mi></msub></mrow><mo>}</mo></mrow></mrow></mstyle></mrow><mo>]</mo></mrow><mo>‚</mo></mrow></math></mathml>
                    </p>
                </div>
                <div class="p1">
                    <p id="165"><i>z</i><sub><i>α</i></sub>为标准正态分布下上100<i>α</i>%分位数, 该式可以进一步转换为:</p>
                </div>
                <div class="p1">
                    <p id="166"><mathml id="167"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mn>1</mn><mo>-</mo><mi>β</mi><mo>=</mo><mtext>Ρ</mtext><mtext>r</mtext><mtext>o</mtext><mtext>b</mtext><mo stretchy="false">[</mo><mstyle displaystyle="true"><munderover><mo>∩</mo><mrow><mi>k</mi><mo>=</mo><mn>1</mn></mrow><mi>Κ</mi></munderover><mo stretchy="false">{</mo></mstyle><mi>Ζ</mi><msubsup><mrow></mrow><mi>k</mi><mo>*</mo></msubsup><mo>&gt;</mo><mi>c</mi><msubsup><mrow></mrow><mi>k</mi><mo>*</mo></msubsup><mo stretchy="false">}</mo><mo stretchy="false">]</mo><mo>=</mo><mtext>Φ</mtext><msub><mrow></mrow><mi>Κ</mi></msub><mo stretchy="false"> (</mo><mo>-</mo><mi>c</mi><msubsup><mrow></mrow><mn>1</mn><mo>*</mo></msubsup><mo>, </mo><mo>⋯</mo><mo>, </mo><mo>-</mo><mi>c</mi><msubsup><mrow></mrow><mi>Κ</mi><mo>*</mo></msubsup><mo stretchy="false">) </mo></mrow></math></mathml>, </p>
                </div>
                <div class="p1">
                    <p id="168">其中, <mathml id="169"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mi>Ζ</mi><msubsup><mrow></mrow><mi>k</mi><mo>*</mo></msubsup><mo>=</mo><mi>Ζ</mi><msub><mrow></mrow><mi>k</mi></msub><mo>-</mo><msqrt><mrow><mi>r</mi><mi>n</mi><mo>/</mo><mo stretchy="false"> (</mo><mn>1</mn><mo>+</mo><mi>r</mi><mo stretchy="false">) </mo></mrow></msqrt><mi>δ</mi><msubsup><mrow></mrow><mi>k</mi><mo>*</mo></msubsup><mo>‚</mo><mi>c</mi><msubsup><mrow></mrow><mi>k</mi><mo>*</mo></msubsup><mo>=</mo><mi>z</mi><msub><mrow></mrow><mi>α</mi></msub><mo>-</mo><msqrt><mrow><mi>r</mi><mi>n</mi><mo>/</mo><mo stretchy="false"> (</mo><mn>1</mn><mo>+</mo><mi>r</mi><mo stretchy="false">) </mo></mrow></msqrt><mi>δ</mi><msubsup><mrow></mrow><mi>k</mi><mo>*</mo></msubsup><mo>‚</mo><mtext>Φ</mtext><msub><mrow></mrow><mi>Κ</mi></msub></mrow></math></mathml>为多元正态分布的累积分布函数 (均数向量为零向量, 协方差阵为<i>ρ</i>) 。在进行样本量估计时, 需通过迭代计算, 当1-<i>β</i>首次达到或者超过预定的全局把握度 (例如80%) 时, 此时的样本量即是满足试验要求的最小样本量。此处采用逐步寻值迭代法, 首先按照预定效应参数值、I类错误水平 (例如0.05) 和II类错误水平 (例如0.20, 相当于把握度为80%) 分别求出<i>K</i>个终点下对应的每组样本量, 选取这<i>K</i>个样本量中最大值作为初值, 每次增加1例, 直到全局把握度至少达到预期水平。</p>
                </div>
                <h4 class="anchor-tag" id="170" name="170">2.方差未知的样本量估计方法</h4>
                <div class="p1">
                    <p id="171">假定<i>σ</i><mathml id="172"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><msubsup><mrow></mrow><mi>k</mi><mn>2</mn></msubsup></mrow></math></mathml>未知, 那么每个终点的均数之差的检验统计量可以用<i>T</i>统计量表示:</p>
                </div>
                <div class="p1">
                    <p id="173" class="code-formula">
                        <mathml id="173"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mi>Τ</mi><msub><mrow></mrow><mi>k</mi></msub><mo>=</mo><mfrac><mrow><mover accent="true"><mi>Y</mi><mo>¯</mo></mover><msub><mrow></mrow><mrow><mn>1</mn><mi>k</mi></mrow></msub><mo>-</mo><mover accent="true"><mi>Y</mi><mo>¯</mo></mover><msub><mrow></mrow><mrow><mn>2</mn><mi>k</mi></mrow></msub></mrow><mrow><mi>s</mi><msub><mrow></mrow><mi>k</mi></msub><msqrt><mrow><mfrac><mn>1</mn><mrow><mi>n</mi><msub><mrow></mrow><mn>1</mn></msub></mrow></mfrac><mo>+</mo><mfrac><mn>1</mn><mrow><mi>n</mi><msub><mrow></mrow><mn>2</mn></msub></mrow></mfrac></mrow></msqrt></mrow></mfrac><mo>‚</mo><mspace width="0.25em" /><mi>k</mi><mo>=</mo><mn>1</mn><mo>, </mo><mo>⋯</mo><mo>‚</mo><mi>Κ</mi><mo>‚</mo></mrow></math></mathml>
                    </p>
                </div>
                <div class="p1">
                    <p id="174"><image id="223" type="formula" href="images/ZGWT201901004_22300.jpg" display="inline" placement="inline"><alt></alt></image>同前, 不再赘述, <i>s</i><sub><i>k</i></sub>为合并标准差, 其计算公式为</p>
                </div>
                <div class="p1">
                    <p id="175"><mathml id="176"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mi>s</mi><msubsup><mrow></mrow><mi>k</mi><mn>2</mn></msubsup><mo>=</mo><mrow><mfrac><mrow><mstyle displaystyle="true"><munderover><mo>∑</mo><mrow><mi>j</mi><mo>=</mo><mn>1</mn></mrow><mrow><mi>n</mi><msub><mrow></mrow><mn>1</mn></msub></mrow></munderover><mrow><mo stretchy="false"> (</mo><mi>Y</mi><msub><mrow></mrow><mrow><mn>1</mn><mi>j</mi><mi>k</mi></mrow></msub><mo>-</mo><mover accent="true"><mi>Y</mi><mo>¯</mo></mover><msub><mrow></mrow><mrow><mn>1</mn><mi>k</mi></mrow></msub><mo stretchy="false">) </mo></mrow></mstyle><msup><mrow></mrow><mn>2</mn></msup><mo>+</mo><mstyle displaystyle="true"><munderover><mo>∑</mo><mrow><mi>j</mi><mo>=</mo><mn>1</mn></mrow><mrow><mi>n</mi><msub><mrow></mrow><mn>2</mn></msub></mrow></munderover><mrow><mo stretchy="false"> (</mo><mi>Y</mi><msub><mrow></mrow><mrow><mn>2</mn><mi>j</mi><mi>k</mi></mrow></msub><mo>-</mo><mover accent="true"><mi>Y</mi><mo>¯</mo></mover><msub><mrow></mrow><mrow><mn>2</mn><mi>k</mi></mrow></msub><mo stretchy="false">) </mo></mrow></mstyle><msup><mrow></mrow><mn>2</mn></msup></mrow><mrow><mi>n</mi><msub><mrow></mrow><mn>1</mn></msub><mo>+</mo><mi>n</mi><msub><mrow></mrow><mn>2</mn></msub><mo>-</mo><mn>2</mn></mrow></mfrac></mrow><msub><mrow></mrow><mrow></mrow></msub></mrow></math></mathml>, </p>
                </div>
                <div class="p1">
                    <p id="177">设<mathml id="178"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mi>D</mi><mo>=</mo><mo stretchy="false"> (</mo><mi>D</mi><msub><mrow></mrow><mn>1</mn></msub><mo>, </mo><mo>⋯</mo><mo>, </mo><mi>D</mi><msub><mrow></mrow><mi>Κ</mi></msub><mo stretchy="false">) </mo><msup><mrow></mrow><mtext>Τ</mtext></msup><mo>‚</mo><mi>D</mi><msub><mrow></mrow><mi>k</mi></msub><mo>=</mo><mo stretchy="false"> (</mo><mrow><mover accent="true"><mi>Y</mi><mo>¯</mo></mover><msub><mrow></mrow><mrow><mn>1</mn><mi>k</mi></mrow></msub></mrow><mo>-</mo><mover accent="true"><mi>Y</mi><mo>¯</mo></mover><msub><mrow></mrow><mrow><mn>2</mn><mi>k</mi></mrow></msub><mo stretchy="false">) </mo><mo>/</mo><mi>σ</mi><msub><mrow></mrow><mi>k</mi></msub></mrow></math></mathml>, 那么<mathml id="179"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><msqrt><mrow><mi>r</mi><mi>n</mi><mo>/</mo><mo stretchy="false"> (</mo><mn>1</mn><mo>+</mo><mi>r</mi><mo stretchy="false">) </mo></mrow></msqrt><mi>D</mi></mrow></math></mathml>服从<i>K</i>元正态分布, 其均向量为<mathml id="180"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><msqrt><mrow><mi>r</mi><mi>n</mi><mo>/</mo><mo stretchy="false"> (</mo><mn>1</mn><mo>+</mo><mi>r</mi><mo stretchy="false">) </mo></mrow></msqrt><mi>δ</mi><msup><mrow></mrow><mo>*</mo></msup></mrow></math></mathml>, 协方差阵为<i>ρ</i>, 也就是<mathml id="181"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mi>Ν</mi><msub><mrow></mrow><mi>k</mi></msub><mo stretchy="false"> (</mo><msqrt><mrow><mi>r</mi><mi>n</mi><mo>/</mo><mo stretchy="false"> (</mo><mn>1</mn><mo>+</mo><mi>r</mi><mo stretchy="false">) </mo></mrow></msqrt><mi>δ</mi><msup><mrow></mrow><mo>*</mo></msup><mo>, </mo><mi>ρ</mi><mo stretchy="false">) </mo></mrow></math></mathml>。此外, 平方和与交叉乘积和组合成的矩阵<i>W</i>服从自由度为<i>n</i> (<i>r</i>+1) -2、协方差阵为<i>ρ</i>的Wishart分布, </p>
                </div>
                <div class="p1">
                    <p id="182" class="code-formula">
                        <mathml id="182"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mi>W</mi><mo>=</mo><mrow><mo> (</mo><mrow><mtable><mtr><mtd><mi>w</mi><msub><mrow></mrow><mrow><mn>1</mn><mn>1</mn></mrow></msub></mtd><mtd><mo>⋯</mo></mtd><mtd><mi>w</mi><msub><mrow></mrow><mrow><mn>1</mn><mi>Κ</mi></mrow></msub></mtd></mtr><mtr><mtd><mo>⋮</mo></mtd><mtd><mo>⋮</mo></mtd><mtd><mo>⋮</mo></mtd></mtr><mtr><mtd><mi>w</mi><msub><mrow></mrow><mrow><mn>1</mn><mi>Κ</mi></mrow></msub></mtd><mtd><mo>⋯</mo></mtd><mtd><mi>w</mi><msub><mrow></mrow><mrow><mi>Κ</mi><mi>Κ</mi></mrow></msub></mtd></mtr></mtable></mrow><mo>) </mo></mrow></mrow></math></mathml>
                    </p>
                </div>
                <div class="p1">
                    <p id="184" class="code-formula">
                        <mathml id="184"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mi>w</mi><msub><mrow></mrow><mrow><mi>k</mi><msup><mi>k</mi><mo>′</mo></msup></mrow></msub><mo>=</mo><mrow><mo>{</mo><mtable columnalign="left"><mtr><mtd><mi>σ</mi><msubsup><mrow></mrow><mi>k</mi><mrow><mo>-</mo><mn>2</mn></mrow></msubsup><mstyle displaystyle="true"><munderover><mo>∑</mo><mrow><mi>j</mi><mo>=</mo><mn>1</mn></mrow><mrow><mi>n</mi><msub><mrow></mrow><mn>1</mn></msub></mrow></munderover><mrow><mo stretchy="false"> (</mo><mi>Y</mi><msub><mrow></mrow><mrow><mn>1</mn><mi>j</mi><mi>k</mi></mrow></msub><mo>-</mo><mover accent="true"><mi>Y</mi><mo>¯</mo></mover><msub><mrow></mrow><mrow><mn>1</mn><mi>k</mi></mrow></msub><mo stretchy="false">) </mo></mrow></mstyle><msup><mrow></mrow><mn>2</mn></msup><mo>+</mo><mi>σ</mi><msubsup><mrow></mrow><mi>k</mi><mrow><mo>-</mo><mn>2</mn></mrow></msubsup><mstyle displaystyle="true"><munderover><mo>∑</mo><mrow><mi>j</mi><mo>=</mo><mn>1</mn></mrow><mrow><mi>n</mi><msub><mrow></mrow><mn>2</mn></msub></mrow></munderover><mrow><mo stretchy="false"> (</mo><mi>Y</mi><msub><mrow></mrow><mrow><mn>2</mn><mi>j</mi><mi>k</mi></mrow></msub><mo>-</mo><mover accent="true"><mi>Y</mi><mo>¯</mo></mover><msub><mrow></mrow><mrow><mn>2</mn><mi>k</mi></mrow></msub><mo stretchy="false">) </mo></mrow></mstyle><msup><mrow></mrow><mn>2</mn></msup><mo>, </mo><mi>k</mi><mo>=</mo><msup><mi>k</mi><mo>′</mo></msup><mo>, </mo></mtd></mtr><mtr><mtd><mi>σ</mi><msubsup><mrow></mrow><mi>k</mi><mrow><mo>-</mo><mn>1</mn></mrow></msubsup><mi>σ</mi><msubsup><mrow></mrow><msup><mi>k</mi><mo>′</mo></msup><mrow><mo>-</mo><mn>1</mn></mrow></msubsup><mstyle displaystyle="true"><munderover><mo>∑</mo><mrow><mi>j</mi><mo>=</mo><mn>1</mn></mrow><mrow><mi>n</mi><msub><mrow></mrow><mn>1</mn></msub></mrow></munderover><mo stretchy="false"> (</mo></mstyle><mi>Y</mi><msub><mrow></mrow><mrow><mn>1</mn><mi>j</mi><mi>k</mi></mrow></msub><mo>-</mo><mover accent="true"><mi>Y</mi><mo>¯</mo></mover><msub><mrow></mrow><mrow><mn>1</mn><mi>k</mi></mrow></msub><mo stretchy="false">) </mo><mo stretchy="false"> (</mo><mi>Y</mi><msub><mrow></mrow><mrow><mn>1</mn><mi>j</mi><msup><mi>k</mi><mo>′</mo></msup></mrow></msub><mo>-</mo><mover accent="true"><mi>Y</mi><mo>¯</mo></mover><msub><mrow></mrow><mrow><mn>1</mn><msup><mi>k</mi><mo>′</mo></msup></mrow></msub><mo stretchy="false">) </mo><mo>+</mo><mi>σ</mi><msubsup><mrow></mrow><mi>k</mi><mrow><mo>-</mo><mn>1</mn></mrow></msubsup><mi>σ</mi><msubsup><mrow></mrow><msup><mi>k</mi><mo>′</mo></msup><mrow><mo>-</mo><mn>1</mn></mrow></msubsup><mstyle displaystyle="true"><munderover><mo>∑</mo><mrow><mi>j</mi><mo>=</mo><mn>1</mn></mrow><mrow><mi>n</mi><msub><mrow></mrow><mn>2</mn></msub></mrow></munderover><mo stretchy="false"> (</mo></mstyle><mi>Y</mi><msub><mrow></mrow><mrow><mn>2</mn><mi>j</mi><mi>k</mi></mrow></msub><mo>-</mo><mover accent="true"><mi>Y</mi><mo>¯</mo></mover><msub><mrow></mrow><mrow><mn>2</mn><mi>k</mi></mrow></msub><mo stretchy="false">) </mo><mo stretchy="false"> (</mo><mi>Y</mi><msub><mrow></mrow><mrow><mn>2</mn><mi>j</mi><msup><mi>k</mi><mo>′</mo></msup></mrow></msub><mo>-</mo><mover accent="true"><mi>Y</mi><mo>¯</mo></mover><msub><mrow></mrow><mrow><mrow></mrow><msub><mrow></mrow><mrow><mn>2</mn><msup><mi>k</mi><mo>′</mo></msup></mrow></msub></mrow></msub><mo stretchy="false">) </mo><mo>, </mo><mi>k</mi><mo>≠</mo><msup><mi>k</mi><mo>′</mo></msup><mo>, </mo></mtd></mtr></mtable></mrow></mrow></math></mathml>
                    </p>
                </div>
                <div class="p1">
                    <p id="185">因此, 统计量<mathml id="186"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mi>Τ</mi><msub><mrow></mrow><mi>k</mi></msub><mo>=</mo><mfrac><mrow><msqrt><mrow><mi>r</mi><mi>n</mi><mo>/</mo><mo stretchy="false"> (</mo><mn>1</mn><mo>+</mo><mi>r</mi><mo stretchy="false">) </mo></mrow></msqrt><mi>D</mi><msub><mrow></mrow><mi>k</mi></msub></mrow><mrow><msqrt><mrow><mfrac><mrow><mi>w</mi><msub><mrow></mrow><mrow><mi>k</mi><mi>k</mi></mrow></msub></mrow><mrow><mi>n</mi><mo stretchy="false"> (</mo><mi>r</mi><mo>+</mo><mn>1</mn><mo stretchy="false">) </mo><mo>-</mo><mn>2</mn></mrow></mfrac></mrow></msqrt></mrow></mfrac></mrow></math></mathml>, 全局把握度为:<mathml id="188"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mn>1</mn><mo>-</mo><mi>β</mi><mo>=</mo><mtext>Ρ</mtext><mtext>r</mtext><mtext>o</mtext><mtext>b</mtext><mo stretchy="false">[</mo><mstyle displaystyle="true"><munderover><mo>∩</mo><mrow><mi>k</mi><mo>=</mo><mn>1</mn></mrow><mi>Κ</mi></munderover><mo stretchy="false">{</mo></mstyle><mi>Τ</mi><msub><mrow></mrow><mi>k</mi></msub><mo>&gt;</mo><mi>t</mi><msub><mrow></mrow><mrow><mi>α</mi><mo>, </mo><mi>n</mi><mo stretchy="false"> (</mo><mi>r</mi><mo>+</mo><mn>1</mn><mo stretchy="false">) </mo><mo>-</mo><mn>2</mn></mrow></msub><mo stretchy="false">}</mo><mo stretchy="false">]</mo></mrow></math></mathml>。</p>
                </div>
                <div class="p1">
                    <p id="189"><i>t</i><sub><i>α</i>, <i>n</i> (<i>r</i>+1) -2</sub>为自由度为<i>n</i> (<i>r</i>+1) -2的<i>t</i>分布上100<i>α</i>%分位数, 如果<i>K</i>=1, 那么全局把握度1-<i>β</i>的计算将基于非中心<i>t</i>分布。当<i>K</i>≥2时, <i>T</i><sub><i>k</i></sub>并不是一个多元非中心<i>t</i>分布, 因为<i>w</i><sub><i>kk</i>′</sub>是Wishart分布, 而Wishart分布不属于多元gamma分布。因此重新定义的全局把握度1-<i>β</i>如下:</p>
                </div>
                <div class="p1">
                    <p id="190">1-<i>β</i>=</p>
                </div>
                <div class="p1">
                    <p id="191" class="code-formula">
                        <mathml id="191"><math xmlns="http://www.w3.org/1998/Math/MathML"><mtable columnalign="left"><mtr><mtd><mtext>Ρ</mtext><mtext>r</mtext><mtext>o</mtext><mtext>b</mtext><mrow><mo>[</mo><mrow><mstyle displaystyle="true"><munderover><mo>∩</mo><mrow><mi>k</mi><mo>=</mo><mn>1</mn></mrow><mi>Κ</mi></munderover><mrow><mrow><mo>{</mo><mrow><msqrt><mrow><mfrac><mrow><mi>r</mi><mi>n</mi></mrow><mrow><mn>1</mn><mo>+</mo><mi>r</mi></mrow></mfrac></mrow></msqrt><mi>D</mi><msub><mrow></mrow><mi>k</mi></msub><mo>&gt;</mo><mi>t</mi><msub><mrow></mrow><mrow><mi>α</mi><mo>, </mo><mi>n</mi><mo stretchy="false"> (</mo><mi>r</mi><mo>+</mo><mn>1</mn><mo stretchy="false">) </mo><mo>-</mo><mn>2</mn></mrow></msub><msqrt><mrow><mfrac><mrow><mi>w</mi><msub><mrow></mrow><mrow><mi>k</mi><mi>k</mi></mrow></msub></mrow><mrow><mi>n</mi><mo stretchy="false"> (</mo><mi>r</mi><mo>+</mo><mn>1</mn><mo stretchy="false">) </mo><mo>-</mo><mn>2</mn></mrow></mfrac></mrow></msqrt></mrow><mo>}</mo></mrow></mrow></mstyle></mrow><mo>]</mo></mrow></mtd></mtr><mtr><mtd><mo>=</mo><mi>E</mi><mrow><mo>[</mo><mtable columnalign="left"><mtr><mtd></mtd></mtr><mtr><mtd><mtext>Ρ</mtext><mtext>r</mtext><mtext>o</mtext><mtext>b</mtext><mo stretchy="false">[</mo><mstyle displaystyle="true"><munderover><mo>∩</mo><mrow><mi>k</mi><mo>=</mo><mn>1</mn></mrow><mi>Κ</mi></munderover><mo stretchy="false">{</mo></mstyle><mi>Ζ</mi><msubsup><mrow></mrow><mi>k</mi><mo>*</mo></msubsup><mo>&gt;</mo><mi>c</mi><msubsup><mrow></mrow><mi>k</mi><mo>*</mo></msubsup><mo stretchy="false"> (</mo><mi>w</mi><msub><mrow></mrow><mrow><mi>k</mi><mi>k</mi></mrow></msub><mo stretchy="false">) </mo><mo stretchy="false">}</mo><mo stretchy="false">|</mo><mi>W</mi><mo stretchy="false">]</mo></mtd></mtr><mtr><mtd></mtd></mtr></mtable><mo>]</mo></mrow></mtd></mtr><mtr><mtd><mo>=</mo><mi>E</mi><mo stretchy="false">[</mo><mtext>Φ</mtext><msub><mrow></mrow><mi>Κ</mi></msub><mo stretchy="false"> (</mo><mo>-</mo><mi>c</mi><msubsup><mrow></mrow><mn>1</mn><mo>*</mo></msubsup><mo stretchy="false"> (</mo><mi>w</mi><msub><mrow></mrow><mrow><mi>k</mi><mi>k</mi></mrow></msub><mo stretchy="false">) </mo><mo>, </mo><mo>⋯</mo><mo>, </mo><mo>-</mo><mi>c</mi><msubsup><mrow></mrow><mi>Κ</mi><mo>*</mo></msubsup><mo stretchy="false"> (</mo><mi>w</mi><msub><mrow></mrow><mrow><mi>Κ</mi><mi>Κ</mi></mrow></msub><mo stretchy="false">) </mo><mo stretchy="false">) </mo><mo stretchy="false">]</mo></mtd></mtr><mtr><mtd><mi>c</mi><msubsup><mrow></mrow><mi>k</mi><mo>*</mo></msubsup><mo stretchy="false"> (</mo><mi>w</mi><msub><mrow></mrow><mrow><mi>k</mi><mi>k</mi></mrow></msub><mo stretchy="false">) </mo><mo>=</mo><mi>t</mi><msub><mrow></mrow><mrow><mi>α</mi><mo>, </mo><mi>n</mi><mo stretchy="false"> (</mo><mi>r</mi><mo>+</mo><mn>1</mn><mo stretchy="false">) </mo><mo>-</mo><mn>2</mn></mrow></msub><msqrt><mrow><mfrac><mrow><mi>w</mi><msub><mrow></mrow><mrow><mi>k</mi><mi>k</mi></mrow></msub></mrow><mrow><mi>n</mi><mo stretchy="false"> (</mo><mi>r</mi><mo>+</mo><mn>1</mn><mo stretchy="false">) </mo><mo>-</mo><mn>2</mn></mrow></mfrac></mrow></msqrt><mo>-</mo><msqrt><mrow><mi>r</mi><mi>n</mi><mo>/</mo><mo stretchy="false"> (</mo><mn>1</mn><mo>+</mo><mi>r</mi><mo stretchy="false">) </mo></mrow></msqrt><mi>δ</mi><msubsup><mrow></mrow><mi>k</mi><mo>*</mo></msubsup></mtd></mtr></mtable></math></mathml>
                    </p>
                </div>
                <div class="p1">
                    <p id="192">Φ<sub><i>K</i></sub>是多元正态分布的累积函数, 它的均向量为零向量, 协方差阵为<i>ρ</i>。上式需要通过Monte-Carlo模拟计算, 按照给定的自由度和协方差矩阵, 随机产生Wishart分布, 进而获得Φ<sub><i>K</i></sub>的期望作为全局把握度<citation id="228" type="reference"><link href="118" rel="bibliography" /><sup>[<a class="sup">3</a>]</sup></citation>。</p>
                </div>
                <h3 id="193" name="193" class="anchor-tag"><b>多个共同终点非劣效临床试验样本量估计方法</b></h3>
                <div class="p1">
                    <p id="194">借鉴优效性试验多个共同终点的样本量估计方法, 我们在非劣效试验中对优效性试验中的相关公式进行扩展, 以实现样本量的估计。假定两组的共同终点均为高优指标, 可将<i>δ</i><sup>*</sup><sub><i>k</i></sub>定义为:</p>
                </div>
                <div class="p1">
                    <p id="195" class="code-formula">
                        <mathml id="195"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mi>δ</mi><msubsup><mrow></mrow><mi>k</mi><mo>*</mo></msubsup><mo>=</mo><mfrac><mrow><mtext>Δ</mtext><msub><mrow></mrow><mi>k</mi></msub><mo>+</mo><mo stretchy="false"> (</mo><mi>μ</mi><msub><mrow></mrow><mrow><mn>1</mn><mi>k</mi></mrow></msub><mo>-</mo><mi>μ</mi><msub><mrow></mrow><mrow><mn>2</mn><mi>k</mi></mrow></msub><mo stretchy="false">) </mo></mrow><mrow><mi>σ</mi><msub><mrow></mrow><mi>k</mi></msub></mrow></mfrac></mrow></math></mathml>
                    </p>
                </div>
                <div class="p1">
                    <p id="196"><i>μ</i><sub>1<i>k</i></sub>表示试验组第<i>k</i>个终点的总体均数, <i>μ</i><sub>2<i>k</i></sub>表示对照组第<i>k</i>个终点的总体均数。Δ<sub><i>k</i></sub> (Δ<sub><i>k</i></sub>&gt;0) 表示第<i>k</i>个终点的非劣效界值, <i>σ</i><sub><i>k</i></sub>表示第<i>k</i>个终点试验组或者对照组的标准差 (这里设定试验组和对照组标准差相同, 如果不同则为两组的合并标准差) 。</p>
                </div>
                <div class="p1">
                    <p id="197">根据非劣效试验样本量估计的公式对单个终点分别计算样本量, 其中试验组样本量计算公式为:</p>
                </div>
                <div class="p1">
                    <p id="198"><mathml id="199"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mi>n</mi><msub><mrow></mrow><mrow><mn>1</mn><mi>k</mi></mrow></msub><mo>=</mo><mfrac><mrow><mrow><mo stretchy="false"> (</mo><mi>Ζ</mi><msub><mrow></mrow><mi>α</mi></msub><mo>+</mo><mi>Ζ</mi><msub><mrow></mrow><mi>β</mi></msub><mo stretchy="false">) </mo></mrow><msup><mrow></mrow><mn>2</mn></msup><mi>σ</mi><msub><mrow></mrow><mi>k</mi></msub><mrow></mrow><msup><mrow></mrow><mn>2</mn></msup></mrow><mrow><mrow><mo stretchy="false"> (</mo><mtext>Δ</mtext><msub><mrow></mrow><mi>k</mi></msub><mo>+</mo><mo stretchy="false"> (</mo><mi>μ</mi><msub><mrow></mrow><mrow><mn>1</mn><mi>k</mi></mrow></msub><mo>-</mo><mi>μ</mi><msub><mrow></mrow><mrow><mn>2</mn><mi>k</mi></mrow></msub><mo stretchy="false">) </mo><mo stretchy="false">) </mo></mrow><msup><mrow></mrow><mn>2</mn></msup></mrow></mfrac><mo stretchy="false"> (</mo><mn>1</mn><mo>+</mo><mi>r</mi><mo stretchy="false">) </mo><mspace width="0.25em" /><mo>‚</mo><mi>r</mi><msub><mrow></mrow><mi>k</mi></msub><mo>=</mo><mi>n</mi><msub><mrow></mrow><mrow><mn>2</mn><mi>k</mi></mrow></msub><mo>/</mo><mi>n</mi><msub><mrow></mrow><mrow><mn>1</mn><mi>k</mi></mrow></msub><mspace width="0.25em" /><mo>‚</mo><mi>k</mi><mo>=</mo><mn>1</mn><mo>⋯</mo><mi>Κ</mi></mrow></math></mathml>。</p>
                </div>
                <div class="p1">
                    <p id="200">则对照组的样本量为rn<sub>1</sub> , 总样本量为 (1+r) n<sub>1</sub><citation id="229" type="reference"><link href="130" rel="bibliography" /><link href="132" rel="bibliography" /><sup>[<a class="sup">9</a>,<a class="sup">10</a>]</sup></citation>。选取K个样本量中的最大值作为初值, 套用优效性试验样本量估计的迭代算法, 即可获得非劣效试验的样本量估计结果。</p>
                </div>
                <h3 id="201" name="201" class="anchor-tag"><b>案例分析</b></h3>
                <div class="p1">
                    <p id="202">儿童腹股沟斜疝高位结扎术时间短, 临床上通常采用插喉罩 (laryngeal mask airway, LMA) 静吸复合全麻, 但是喉罩操作对新手存在难度, 拔管时可能出现咬管、喉痉挛等不良事件, 易发生插管部位疼痛、出血等并发症。某医院自主设计了新型通气设备 (new mask airway, NMA) , 希望该设备应用于此类儿童手术在效果上非劣于LMA麻醉方法。该非劣效临床试验主要考察的是通气数据潮气量 (tidal volume, VT) , 需要在多个时间点上均呈现出非劣效才可认定新型设备的非劣效性。根据预实验结果, 假定在3个时间点上两组的VT相同, 其均数±标准差分别为11.0±3.2, 9.5±2.4, 8.6±2.1, 非劣效界值取对照组均数的15%, 分别为1.65、1.425和1.29, 若按照各时间点VT之间相关系数均为0.6 (可允许不同) , 则根据前面介绍的方法, 在I类错误水平取0.025的条件下, 每组用136例可达到80%的全局把握度。本文样本量计算基于R软件编程实现, 部分程序代码见附录。</p>
                </div>
                <div class="p1">
                    <p id="203">为了验证方法的正确性, 我们基于本例非劣效临床试验基本框架进行了Monte-Carlo模拟验证。假定两组的总体均数相同, 按照不同的非劣效界值 (分别取对照组均数的10%、15%和20%, 见表1) 、终点间不同的相关系数 (0、0.2、0.4、0.6、0.8、1.0) 、不同的I类错误水平 (0.025、0.05) 下的不同参数设定, 按照本文介绍的方法进行了全局把握度为80%的样本量估计, 并在相应样本量之下, 按照不同的参数设定随机产生多元正态分布, 模拟10000次, 进行交并检验, 进而求算出全局把握度 (结果见表2) , 通过该模拟把握度与预设把握度的比较验证方法的正确性。</p>
                </div>
                <div class="area_img" id="204">
                    <p class="img_tit"><b>表1</b> 某新型通气设备非劣效界值Δ设置情况 <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="204" border="1"><tr><td><br />Δ设置</td><td>终点1</td><td>终点2</td><td>终点3</td></tr><tr><td><br />对照组均数的10%</td><td>1.1</td><td>0.95</td><td>0.86</td></tr><tr><td><br />对照组均数的15%</td><td>1.65</td><td>1.425</td><td>1.29</td></tr><tr><td><br />对照组均数的20%</td><td>2.2</td><td>1.9</td><td>1.72</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note"></p>
                    <p class="img_note"></p>
                </div>
                <div class="p1">
                    <p id="205">由表2可见, 多个共同终点考虑下的样本量估计结果, 在不同的参数设定下所模拟获得的全局把握度与预设把握度极为接近, 在80%的预设把握度下最多不超过1.5%, 较好地验证了本文方法的正确性。从具体的样本量行为还可看到, 多个共同终点的样本量与相关系数、I错误水平和非劣效界值均直接有关, 随着终点间相关系数的增大而减小, 随着非劣效界值减小而增大, I类错误水平越小, 样本量越大。此外, 在各终点完全相关 (相关系数为1) 时, 多个共同终点考虑下的样本量与按单个终点计算的最大样本量相当, 其他情况下均为前者大于后者。这意味着, 在各个终点完全相关时, 取单个终点的最大样本量可以达到预设的全局把握度, 而在其他情况下, 即使取最大样本量也不能达到预设的全局把握度。</p>
                </div>
                <h3 id="206" name="206" class="anchor-tag"><b>讨</b><b>论</b></h3>
                <div class="p1">
                    <p id="207">本文利用Suzu等提出的多个连续性共同终点优效性临床试验样本量估计的方法, 在阐明其样本量估计的理论基础上, 扩展提出关于多个连续分布共同终点非劣效临床试验的样本量估计方法。结合临床麻醉学中一个重复测量终点非劣效临床试验的实际案例, 基于其预试验的相关结果, 在不同的Ⅰ类错误率水平、各重复测量间不同的相关系数、不同的非劣效界值设定下, 估计了满足一定的全局把握度 (例如80%) 的样本量, 并借助Monte-Carlo模拟方法验证了方法的正确性。此外, 我们还对试验组与对照组均数差值不全为0的情况 (均大于0、均小于0、不全为0) 估计的样本量进行了不同参数设定下的模拟验证, 其全局把握度均能与预设把握度高度吻合, 验证了本文方法的普适性。实例及模拟验证中采用的样本量估计方法为按照方差已知的情形而进行的, 我们同时也按照方差未知的情行进行了计算和模拟, 其结果与方差已知情形相差甚微, 在本实例的参数设定框架下仅相差1例。相关的验证结果因篇幅所限未列出。本文介绍的样本量估计方法具有严密的统计理论基础, 能较好地保护全局把握度, 具有较强的实用价值, 可望为多个连续分布共同终点非劣效临床试验的样本量估计提供有力的方法学支持。</p>
                </div>
                <div class="area_img" id="208">
                    <p class="img_tit"><b>表2</b> 全局把握度为80%不同参数设定下的样本量估计及Monte-Carlo模拟结果及 <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="208" border="1"><tr><td rowspan="2"><i>ρ</i></td><td rowspan="2"><i>Δ</i></td><td rowspan="2"><i>α</i></td><td colspan="3"><br />单终点样本量</td><td rowspan="2">样本量</td><td rowspan="2">模拟的全<br />局把握度 (%) </td></tr><tr><td><br />终点1</td><td>终点2</td><td>终点3</td></tr><tr><td>0</td><td>10%</td><td>0.025</td><td>268</td><td>204</td><td>190</td><td>330</td><td>80.01</td></tr><tr><td><br /></td><td></td><td>0.05</td><td>212</td><td>160</td><td>150</td><td>272</td><td>79.81</td></tr><tr><td><br /></td><td>15%</td><td>0.025</td><td>122</td><td>92</td><td>86</td><td>148</td><td>79.76</td></tr><tr><td><br /></td><td></td><td>0.05</td><td>96</td><td>72</td><td>68</td><td>122</td><td>80.54</td></tr><tr><td><br /></td><td>20%</td><td>0.025</td><td>70</td><td>54</td><td>50</td><td>84</td><td>80.51</td></tr><tr><td><br /></td><td></td><td>0.05</td><td>54</td><td>42</td><td>40</td><td>68</td><td>79.70</td></tr><tr><td><br />0.2</td><td>10%</td><td>0.025</td><td>268</td><td>204</td><td>190</td><td>324</td><td>79.69</td></tr><tr><td><br /></td><td></td><td>0.05</td><td>212</td><td>160</td><td>150</td><td>266</td><td>80.20</td></tr><tr><td><br /></td><td>15%</td><td>0.025</td><td>122</td><td>92</td><td>86</td><td>144</td><td>78.87</td></tr><tr><td><br /></td><td></td><td>0.05</td><td>96</td><td>72</td><td>68</td><td>118</td><td>78.97</td></tr><tr><td><br /></td><td>20%</td><td>0.025</td><td>70</td><td>54</td><td>50</td><td>82</td><td>79.36</td></tr><tr><td><br /></td><td></td><td>0.05</td><td>54</td><td>42</td><td>40</td><td>68</td><td>80.55</td></tr><tr><td><br />0.4</td><td>10%</td><td>0.025</td><td>268</td><td>204</td><td>190</td><td>316</td><td>80.06</td></tr><tr><td><br /></td><td></td><td>0.05</td><td>212</td><td>160</td><td>150</td><td>258</td><td>79.76</td></tr><tr><td><br /></td><td>15%</td><td>0.025</td><td>122</td><td>92</td><td>86</td><td>140</td><td>79.42</td></tr><tr><td><br /></td><td></td><td>0.05</td><td>96</td><td>72</td><td>68</td><td>116</td><td>80.26</td></tr><tr><td><br /></td><td>20%</td><td>0.025</td><td>70</td><td>54</td><td>50</td><td>80</td><td>79.81</td></tr><tr><td><br /></td><td></td><td>0.05</td><td>54</td><td>42</td><td>40</td><td>66</td><td>80.06</td></tr><tr><td><br />0.6</td><td>10%</td><td>0.025</td><td>268</td><td>204</td><td>190</td><td>304</td><td>79.69</td></tr><tr><td><br /></td><td></td><td>0.05</td><td>212</td><td>160</td><td>150</td><td>246</td><td>79.69</td></tr><tr><td><br /></td><td>15%</td><td>0.025</td><td>122</td><td>92</td><td>86</td><td>136</td><td>80.68</td></tr><tr><td><br /></td><td></td><td>0.05</td><td>96</td><td>72</td><td>68</td><td>110</td><td>79.26</td></tr><tr><td><br /></td><td>20%</td><td>0.025</td><td>70</td><td>54</td><td>50</td><td>76</td><td>78.96</td></tr><tr><td><br /></td><td></td><td>0.05</td><td>54</td><td>42</td><td>40</td><td>62</td><td>79.87</td></tr><tr><td><br />0.8</td><td>10%</td><td>0.025</td><td>268</td><td>204</td><td>190</td><td>286</td><td>79.33</td></tr><tr><td><br /></td><td></td><td>0.05</td><td>212</td><td>160</td><td>150</td><td>230</td><td>80.31</td></tr><tr><td><br /></td><td>15%</td><td>0.025</td><td>122</td><td>92</td><td>86</td><td>128</td><td>80.01</td></tr><tr><td><br /></td><td></td><td>0.05</td><td>96</td><td>72</td><td>68</td><td>104</td><td>80.05</td></tr><tr><td><br /></td><td>20%</td><td>0.025</td><td>70</td><td>54</td><td>50</td><td>72</td><td>78.52</td></tr><tr><td><br /></td><td></td><td>0.05</td><td>54</td><td>42</td><td>40</td><td>58</td><td>78.72</td></tr><tr><td><br />1</td><td>10%</td><td>0.025</td><td>268</td><td>204</td><td>190</td><td>266</td><td>80.08</td></tr><tr><td><br /></td><td></td><td>0.05</td><td>212</td><td>160</td><td>150</td><td>210</td><td>79.50</td></tr><tr><td><br /></td><td>15%</td><td>0.025</td><td>122</td><td>92</td><td>86</td><td>120</td><td>80.22</td></tr><tr><td><br /></td><td></td><td>0.05</td><td>96</td><td>72</td><td>68</td><td>94</td><td>80.57</td></tr><tr><td><br /></td><td>20%</td><td>0.025</td><td>70</td><td>54</td><td>50</td><td>68</td><td>79.74</td></tr><tr><td><br /></td><td></td><td>0.05</td><td>54</td><td>42</td><td>40</td><td>54</td><td>80.69</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note">*:<i>ρ</i>各终点间相关系数, <i>Δ</i>:非劣效界值, <i>α</i>:I类错误水平</p>
                    <p class="img_note"></p>
                </div>
                <div class="p1">
                    <p id="210">对于临床试验中存在多个共同终点的情形, 传统的确定样本量的方法是对II类错误水平进行校正<citation id="230" type="reference"><link href="134" rel="bibliography" /><sup>[<a class="sup">11</a>]</sup></citation>, 然后按各单个主要终点分别计算所需的样本量, 并从中选取最大值作为最终样本量, 以保护全局把握度。该方法没有考虑各终点间的相关性, 所给出的最终样本量为单个终点样本量中的最大值, 必然造成其他终点把握度的膨胀, 从而导致全局把握度的浪费。而如果不校正II类错误水平, 选取单个终点样本量中的最大值作为最终样本量, 则全局把握度明显不足。本文提出的方法很好地解决了此问题。</p>
                </div>
                <div class="p1">
                    <p id="211">本文实例的终点为重复测量数据, 似乎并不是典型的共同终点情形, 但从研究目的和临床实际的角度上考虑, 由于3个重复测量点均需要达到非劣效方可最终推断新型通气设备的非劣效性, 恰巧符合共同终点的定义, 因此完全可视为3个共同终点而采用本文介绍的样本量估计方法。无疑, 该应用为重复测量临床试验样本量估计提供了一种新的思路。</p>
                </div>
                <div class="p1">
                    <p id="212">值得注意的是, 由于实际中相关系数一般是未知的, 尽管可以从以往的文献中寻找或者通过预实验获得, 但不能过于激进, 宜采用相关系数的保守结果, 以免全局把握度不足。鉴于多终点临床试验样本量估计的复杂性, 有学者曾提出将多个终点合成为一个复合终点<citation id="231" type="reference"><link href="136" rel="bibliography" /><sup>[<a class="sup">12</a>]</sup></citation>, 可一定程度上解决样本量估计和统计推断的问题, 但在许多情况下该做法并不被接受。</p>
                </div>

        <!--brief end-->
        
        <!--conten left  end-->
        <!--增强附件-->
        

        <!--reference start-->
            <div class="reference anchor-tag" id="a_bibliography">
                    <h3>参考文献</h3>
                                        <p id="114">
                            <a id="bibliography_1" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Sample Size Determination in Clinical Trials with Multiple Endpoints">

                                <b>[1]</b> Sozu T, Sugimoto T, Hamasaki T, et al.Sample Size Determination in Clinical Trials with Multiple Endpoints.Springer International Publishing, 2015, 29 (21) :2169-2179.
                            </a>
                        </p>
                        <p id="116">
                            <a id="bibliography_2" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Commentary: Changes are still needed on multiple co-primary endpoints: Changes Are Still Needed on Multiple Co-Primary Endpoints">

                                <b>[2]</b> Chuang-Stein C, Li JD.Commentary: Changes are still needed on multiple co-primary endpoints: Changes Are Still Needed on Multiple Co-Primary Endpoints.Statistics in Medicine, 2017, 36 (28) :4427-4436.
                            </a>
                        </p>
                        <p id="118">
                            <a id="bibliography_3" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Multiple Co-primary Endpoints: Medical and Statistical Solutions: A Report from the Multiple Endpoints Expert Team of the Pharmaceutical Research and Manufacturers of America">

                                <b>[3]</b> Offen W, Chuang-Stein C, Dmitrienko A, et al.Multiple Co-primary Endpoints: Medical and Statistical Solutions: A Report from the Multiple Endpoints Expert Team of the Pharmaceutical Research and Manufacturers of America.Therapeutic Innovation &amp; Regulatory Science, 2007, 41 (1) :31-46.
                            </a>
                        </p>
                        <p id="120">
                            <a id="bibliography_4" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Guideline on medicinal products for the treatment of Alzheimer&amp;#39;&amp;#39;s disease and other dementias">

                                <b>[4]</b> Committee for Medicinal Products for Human Use.Guideline on Medical Productsfor the Treatment Alzheimer’ Disease and Other Dementias (CPMP/EWP/553/95Rev.1) .European Medicines Agency, London, July 24, 2008.
                            </a>
                        </p>
                        <p id="122">
                            <a id="bibliography_5" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Draft Guidance for Industry.Irritable Bowel Syndrome: Clinical Evaluation of Products for Treatment">

                                <b>[5]</b> Food and Drug Administration.Draft Guidance for Industry.Irritable Bowel Syndrome: Clinical Evaluation of Products for Treatment.Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, MD, March, 2010.
                            </a>
                        </p>
                        <p id="124">
                            <a id="bibliography_6" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Design,data monitoring,and analysis of clinical trials with co-primary endpoints: A review">

                                <b>[6]</b> Hamasaki T, Evans SR, Asakura K.Design, data monitoring, and analysis of clinical trials with co-primary endpoints: A review.Journal of Biopharmaceutical Statistics, 2017, 28 (1) :28-51.
                            </a>
                        </p>
                        <p id="126">
                            <a id="bibliography_7" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZGWT201305016&amp;v=MjExMjhIOUxNcW85RVlvUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabkZ5L2hXNzdBUHlyY2VyRzQ=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRsbWlzblVrRUNCMVZEemR5T1VRND0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[7]</b> 吴振强, 李卫, 孙业桓, 等.存在共同终点的优效性临床试验样本量问题探讨.中国卫生统计, 2013, 30 (5) :680-682.
                            </a>
                        </p>
                        <p id="128">
                            <a id="bibliography_8" target="_blank" href="/kcms/detail/detail.aspx?dbcode=STJD&amp;filename=STJD120604069062&amp;v=MTA5OTFmWmVadkZ5bnNVN2pNS0Y4Y05qbkJhcks2SHRmTXE0OURiZXNKRGhNOHp4VVNtRGQ5U0g3bjN4RTlmYnZuS3Jp&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRsbWlzblVrRUNCMVZEemR5T1VRND0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[8]</b> Sozu T, Sugimoto T, Hamasaki T.Sample size determination in superiority clinical trials with multiple co-primary correlated endpoints.Journal of Biopharmaceutical Statistics, 2011, 21 (4) :650-668.
                            </a>
                        </p>
                        <p id="130">
                            <a id="bibliography_9" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CBBD&amp;filename=9787117200714000&amp;v=MTQwNTA3bjN4RTlmYnZuS3JpZlplWnZGeW5zVTdqTUtGOGNYRnF6R2JLNUdkUE1yNGhFWU9zUERCTTh6eFVTbURkOVNI&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRsbWlzblVrRUNCMVZEemR5T1VRND0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[9]</b> 陈峰, 于浩.临床试验精选案例统计学解读.第1版.北京:人民卫生出版社, 2015:141-162
                            </a>
                        </p>
                        <p id="132">
                            <a id="bibliography_10" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=GLYZ200006013&amp;v=MTU1NTJxWTlFWjRRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVpuRnkvaFc3N0FJaUhTZExHNEh0SE0=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRsbWlzblVrRUNCMVZEemR5T1VRND0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[10]</b> 刘玉秀, 姚晨, 陈峰, 等.非劣效性/等效性试验中的统计学分析.中国临床药理学杂志, 2000, 16 (6) :448-452.
                            </a>
                        </p>
                        <p id="134">
                            <a id="bibliography_11" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=YLZL201708015&amp;v=MTI5MTZZWVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm5GeS9oVzc3QVBDSFJZckc0SDliTXA0OUU=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRsbWlzblVrRUNCMVZEemR5T1VRND0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[11]</b> 陆梦洁, 刘玉秀, 卢光明, 等.单组目标值临床试验多指标时的样本量估计.中国临床药理学与治疗学, 2017, 22 (8) :917-921.
                            </a>
                        </p>
                        <p id="136">
                            <a id="bibliography_12" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZGWT201402017&amp;v=MjgxOTQvaFc3N0FQeXJjZXJHNEg5WE1yWTlFWTRRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVpuRnk=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRsbWlzblVrRUNCMVZEemR5T1VRND0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[12]</b> 郭正梅, 阎小妍, 姚晨.两个有序分类变量构建一个分类复合终点指标方法的模拟评价.中国卫生统计, 2014, 31 (2) :245-250.
                            </a>
                        </p>
            </div>
        <!--reference end-->
        <!--footnote start-->
        <!--footnote end-->



    </div>

        <input id="fileid" type="hidden" value="ZGWT201901004" />
        <input id="dpi" type="hidden" value="300" />
    </div>

<script>
var _hmt = _hmt || [];
(function() {
  var hm = document.createElement("script");
  hm.src = "https://hm.baidu.com/hm.js?6e967eb120601ea41b9d312166416aa6";
  var s = document.getElementsByTagName("script")[0];
  s.parentNode.insertBefore(hm, s);
})();
</script>

    


<input id="hid_uid" name="hid_uid" type="hidden" value="WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRsbWlzblVrRUNCMVZEemR5T1VRND0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" />
<input id="hid_kLogin_headerUrl" name="hid_kLogin_headerUrl" type="hidden" value="/KLogin/Request/GetKHeader.ashx%3Fcallback%3D%3F" />
<input id="hid_kLogin_footerUrl" name="hid_kLogin_footerUrl" type="hidden" value="/KLogin/Request/GetKFooter.ashx%3Fcallback%3D%3F" />
<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZGWT201901004&amp;v=MTY1OTMzenFxQnRHRnJDVVI3cWZadVpuRnkvaFc3N0FQeXJjZXJHNEg5ak1ybzlGWUlRS0RIODR2UjRUNmo1NE8=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRsbWlzblVrRUNCMVZEemR5T1VRND0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>
<div class="popflow" id="popupTips" style="display: none;">
    <div class="popflowArr"></div>
    <div class="popflowCot">
        <div class="hd"><a href="javascript:void(0);" onclick="$('#popupTips').hide();$('#popupmsg').html('')" class="close">X</a></div>
        <div class="bd">
            <p class="mes" id="popupmsg" name="popupmsg"></p>
          
        </div>
    </div>
</div>
<input type="hidden" id="myexport" value="//kns.cnki.net" />

<input type="hidden" id="KPCAPIPATH" value="//ishufang.cnki.net" />
<input type="hidden" id="CitedTimes" value="1" />
<div class="link" id="GLSearch" style="display: none;">
    <i class="icon-trangle"></i>
    <div class="inner">
        <a class="icon" id="copytext">复制</a>
        <a class="icon" target="_blank" onclick="searchCRFD(this)">工具书搜索</a>
    </div>
</div>




<input id="hidVirtualPath" name="hidVirtualPath" type="hidden" value="/kxreader" />
<script src="/kxreader/bundles/detail?v=842_VlRz_g1CMCLi-M0twVw-4EOFG_noWyi_OsMnrAg1"></script>

<script src="/kxreader/Scripts/layer.min.js" type="text/javascript"></script>

<div id="footerBox" class="rootw footer">
</div>
<script>
    if (typeof FlushLogin == 'function') {
        FlushLogin();
    }
    modifyEcpHeader(true);
</script>

<!--图片放大功能 start-->
<script src="/kxreader/bundles/imagebox?v=W4phPu9SNkGcuPeJclikuVE3PpRyIW_gnfjm_19nynI1"></script>

<script type="text/javascript">
    $(function () {
        var j = $.noConflict();
        j(function () {
            j(".zoom-in,.btn-zoomin").imgbox({
                'alignment': 'center',
                'allowMultiple': false,
                'overlayShow': true
            });
        })
    });
</script>
<!--图片放大功能 end-->
<div class="fixedbar">
    <div class="backtop hiddenV" id="backtop">
        <a id="backTopSide" href="javascript:scroll(0,0);" title=""></a>
    </div>
</div>
<script type="text/javascript" src="/kxreader/Scripts/MathJax-2.6-latest/MathJax.js?config=MML_HTMLorMML-full"></script>

</body>
</html>
